Rhinosinusitis Clinical Trials

84 clinical trials for Rhinosinusitis across international registries, including 22 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Longitudinal Deep Phenotyping of Central Mechanisms in Dysosmia: A Pilot Study Using Electrobulbogram (EBG), Functional MRI (fMRI), and Diffusion-Weighted Imaging (DWI) — RECRUITING
• RhinAV_Evaluation of Treatments for Acute Viral Rhinitis, Rhinosinusitis, and Rhinopharyngitis — RECRUITING · NA
• Nasal Potential Difference (NPD) Protocol in Chronic Rhinosinusitis — RECRUITING
• The Efficacy and Safety of Raphamin in the Treatment of Acute Rhinosinusitis in Adult Patients — RECRUITING · PHASE3
• A DOUBLE-BLINDED EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY AND TOLERABILITY OF ITEPEKIMAB IN ADULT PARTICIPANTS WITH INADEQUATELY CONTROLLED CHRONIC RHINOSINUSITIS WITH NASAL POLYPS (CRSWNP) WHO PARTICIPATED IN EITHER EFC18418 OR EFC18419 CLINICAL STUDIES — RECRUITING
• Performance and Safety Assessment of the Mechanical Decongestant Seawater Spray Enriched With Essential Oils From Laboratoires Gilbert in Patient With Acute Rhinitis Associated With Nasal Obstruction — RECRUITING
• THE EFFICACY OF INTRA-SINUS POVIDONE-IODINE/BUDESONIDE GEL FORMING SUSPENSION FOLLOWING ENDOSCOPIC SINUS SURGERY FOR CHRONIC RHINOSINUSITIS: A RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED TRIAL — RECRUITING
• Safety and Performance Assessment of the Decongestant Seawater Spray Pocket Valve Enriched With Essential Oils in Patients With Acute Rhinitis Associated With Nasal Obstruction: "DEVALPO" — RECRUITING · NA
• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, 52-WEEK PHASE 3 TRIAL TO INVESTIGATE THE EFFICACY, SAFETY, AND TOLERABILITY OF ITEPEKIMAB IN ADULT PARTICIPANTS WITH INADEQUATELY-CONTROLLED CHRONIC RHINOSINUSITIS WITH NASAL POLYPS — RECRUITING · PHASE3
• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, 52-WEEK PHASE 3 TRIAL TO INVESTIGATE THE EFFICACY, SAFETY, AND TOLERABILITY OF ITEPEKIMAB IN ADULT PARTICIPANTS WITH INADEQUATELY-CONTROLLED CHRONIC RHINOSINUSITIS WITH NASAL POLYPS — RECRUITING · PHASE3
• OPENING THE 'BLACK BOX' ON TEZEPELUMAB'S EFFECT OF CHRONIC RHINOSINUSITIS WITH SEVERE ASTHMA — RECRUITING
• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PROOF-OF-CONCEPT (POC) STUDY TO ASSESS THE EFFICACY, SAFETY, AND TOLERABILITY OF ITEPEKIMAB IN PARTICIPANTS WITH INADEQUATELY CONTROLLED CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYPS — RECRUITING
• A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LEBRIKIZUMAB/LY3650150 IN ADULT PARTICIPANTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPS ON BACKGROUND INTRANASAL CORTICOSTEROIDS — RECRUITING · PHASE3
• MULTICENTER, RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED, PHASE 2 CLINICAL EFFICACY STUDY EVALUATING NITRIC OXIDE NASAL SPRAY (NONS) COMPARED TO SALINE NASAL SPRAY AS AN EARLY TREATMENT FOR RECURRENT ACUTE RHINOSINUSITIS (RARS) — RECRUITING · PHASE2
• ¿A RANDOMIZED, DOUBLE-BLIND, HEAD-TO-HEAD COMPARISON OF DUPILUMAB VERSUS OMALIZUMAB IN SEVERE CHRONIC RHINOSINUSITIS WITH NASAL POLYPS (CRSWNP) AND COMORBID ASTHMA PATIENTS — RECRUITING
• A RANDOMISED, DOUBLE-BLIND, PARALLEL GROUP PHASE III STUDY TO ASSESS THE EFFICACY AND SAFETY OF 100 MG SC DEPEMOKIMAB IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPS (CRSWNP) ¿ ANCHOR-1 (DEPEMOKIMAB IN CHRONIC RHINOSINUSITIS) — RECRUITING · PHASE3
• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 2-PART STUDY TO EVALUATE THE EFFICACY AND SAFETY OF DUPILUMAB IN PATIENTS WITH UNCONTROLLED, CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYPOSIS (CRSSNP)¿ — RECRUITING
• A 24-WEEK RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER STUDY EVALUATING THE EFFICACY AND SAFETY OF INTRANASAL ADMINISTRATION OF 186 AND 372 MCG OF OPN-375 TWICE A DAY (BID) IN SUBJECTS WITH CHRONIC RHINOSINUSITIS WITH OR WITHOUT THE PRESENCE OF NASAL POLYPS — RECRUITING
• RANDOMIZED CONTROLLED PARALLEL GROUP TRIAL TO EVALUATE SAFETY & EFFICACY OF TOPICAL NITRIC OXIDE RELEASING SINUS IRRIGATION (NOSI) AS COMPARED TO BUDESONIDE-SALINE (CONTROL) IN THE MANAGEMENT OF BIOFILM-ASSOCIATED RECALCITRANT CHRONIC RHINOSINUSITIS (RCRS) — RECRUITING
• TRANSFER OF SINONASAL MICROBIOTA VIA NASAL LAVAGE FROM A HEALTHY DONOR TO TREAT REFRACTORY CHRONIC RHINOSINUSITIS IN A RECIPIENT PATIENT, A PROSPECTIVE SAFETY AND EFFICACY STUDY — RECRUITING
• A PHASE IA TOLERANCE EVALUATION OF TOPICAL NITRIC OXIDE SINUS IRRIGATION (NOSI) DOSE ESCALATION IN INDIVIDUALS WITH RECALCITRANT CHRONIC RHINOSINUSITIS (RCRS) — RECRUITING · PHASE1
• A PHASE III, RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL OF OMALIZUMAB IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPS — RECRUITING · PHASE3
• Efficacy of Bee Venom Phonophoresis in Treating Chronic Sinusitis: — NOT_YET_RECRUITING · NA
• Observational Study of RHINOSEDAL in Acute Nasal Obstruction — NOT_YET_RECRUITING
• Clinical Outcomes and Patient Satisfaction With Velnez Versus Nasopore in Nasal Surgery — COMPLETED · NA
• Post-market Clinical Follow-up Study of an Isotonic Saline Solution to Manage Nasal Congestion in Case of Flu Symptoms, Colds, Allergic Rhinitis and Rhinosinusitis in Infants and Toddlers — NOT_YET_RECRUITING
• Dexmedetomidine Infusion in Either Total Intravenous Anesthesia or Inhalational Anesthesia to Improve Surgical Field Visibility in Endoscopic Sinus Surgery — COMPLETED · PHASE4
• DETERMINING THE IMMUNOLOGIC IMPACT OF DUPILUMAB ON THE UNIFIED AIRWAY SYSTEM IN PATIENTS SUFFERING FROM ASTHMA AND CHRONIC RHINOSINUSITIS WITH POLYPS — NOT_YET_RECRUITING
• Erenumab for Idiosyncratic Facial Pain — COMPLETED · PHASE4
• Effect of Electromagnetic Therapy on Patients With Chronic Rhinosinusitis. — COMPLETED · NA
• Prospective Study Investigating the Role of Occupational Exposure on Sinus Surgery Outcome — COMPLETED
• Effect of Hot Saline Irrigation on the Operative Field During Endoscopic Sinus Surgery — COMPLETED · NA
• Safety and Efficacy of DSM 32444 Postbiotic in the Treatment of Acute Rhinosinusitis — COMPLETED · NA
• the Prevalence of Chronic Rhinosinusitis Associated With Inflammatory Bowel Disease and Association With Biomarkers of Epithelial Barrier Damage — OTHER
• Prevalence of ENT Diseseas — OTHER
• Physiotherapy Protocol in Treating Chronic Rhinosinusitis — COMPLETED · NA
• A PHASE 2B, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF THE EFFICACY AND SAFETY OF BRENSOCATIB IN PARTICIPANTS WITH CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYPS - THE BIRCH STUDY — COMPLETED · PHASE2
• Effect of Low Level Laser Therapy in Patients With Chronic Rhinosinusitis. — COMPLETED · NA
• Role of Imaging in Complications of Sinusitis — OTHER · NA
• Xylitol for Chronic Sinusitis — COMPLETED · PHASE2
• Tobramycin Delivered by Nebulized Sonic Aerosol for Chronic Rhinosinusitis Treatment of Cystic Fibrosis Patients — TERMINATED · PHASE3
• Efficacy and Safety of Modified Release Cefpodoxime Formulation in the Treatment of Acute Sinusitis. — OTHER · PHASE3
• Buparid/PARI SINUS Versus Budes® Nasal Spray in the Therapy of Chronic Rhinosinusitis With Polyposis Nasi — COMPLETED · PHASE1
• Buparid/PARI SINUS Versus Budes® Nasal Spray in the Therapy of Chronic Rhinosinusitis — COMPLETED · PHASE1
• Efficacy and Safety of Acetylcysteine for the Treatment of Acute Uncomplicated Rhinosinusitis — COMPLETED · PHASE3
• A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED PARALLEL GROUP STUDY ASSESSING THE EFFICACY AND SAFETY OF DUPILUMAB IN PATIENTS WITH ALLERGIC FUNGAL RHINOSINUSITIS (AFRS) — COMPLETED
• A 24-WEEK RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER STUDY EVALUATING THE EFFICACY AND SAFETY OF INTRANASAL ADMINISTRATION OF 186 AND 372 MCG OF OPN-375 TWICE A DAY (BID) IN SUBJECTS WITH CHRONIC RHINOSINUSITIS WITHOUT THE PRESENCE OF NASAL POLYPS — NOT_YET_RECRUITING
• EFFICACY OF SHORT-TERM ORAL CORTICOSTEROIDS IN CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYPS: A RANDOMIZED CONTROLLED TRIAL — NOT_YET_RECRUITING
• Healthcare Utilization and Outcomes of FinESS Treatment in the Office — COMPLETED · NA
• A MULTICENTRE, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED PHASE 3 EFFICACY AND SAFETY STUDY OF BENRALIZUMAB FOR THE PREVENTION OF RECURRENCE OF NASAL POLYPS FOLLOWING SURGICAL REMOVAL IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPS (OXALIS) — NOT_YET_RECRUITING · PHASE3

Refine this search